The major clinical hallmarks of AD are extracellular deposits of β-amyloid peptide (Aβ), resulting from the proteolytic cleavage of the amyloid precursor protein (APP), and intracellular accumulation of tau protein, due to its hyperphosphorylation [86,87]. This evidence concerns the gene APP and Alzheimer disease.